Immunome, Inc.
NASDAQ · us_market
No AI insight generated yet for this ticker.
Immunome, Inc., a biotechnology company, engages in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics in the United States. The company develops clinical asset comprising Varegacestat, a gamma secretase inhibitor that is in Phase 3 clinical trial for the treatment of desmoid tumors; and IM-1021, a receptor tyrosine kinase-like orphan receptor 1 antibody-drug conjugate (ADC), which is in Phase 1 clinical trial. It is also developing preclinical assets, including IM-3050, a fibroblast activation protein targeted radioligand therapy; and solid tumor ADC drug candidates, such as IM-1617, IM-1340, and IM-1335. Immunome, Inc. was incorporated in 2006 and is based in Bothell, Washington.
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| FidelityFMR | fundamental | 16.97M | $371.13M | 0.02% | Added+2.5% | 2026-03-31 |
| StateStreet | passive | 5.40M | $118.10M | 0.00% | Added+39.6% | 2026-03-31 |
| Wellington | fundamental | 4.73M | $103.49M | 0.02% | Added+406.4% | 2026-03-31 |
| RenTech | quant | 68.9K | $1.51M | 0.00% | New | 2026-03-31 |
| TRowePrice | fundamental | 2.86M | $62.52K | 0.01% | Trimmed-15.4% | 2026-03-31 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-08-06upcoming | -0.51 | — | — |
| 2026-03-03 | -0.57 | -0.76 | -32.80% |
| 2025-11-06 | -0.54 | -0.65 | -19.63% |
| 2025-08-06 | -0.50 | -0.50 | -0.29% |
| 2025-05-12 | -0.57 | -0.52 | +9.09% |
| 2025-03-19 | -0.61 | -1.11 | -82.72% |
| 2024-11-13 | -0.58 | -0.78 | -33.72% |
| 2024-08-12 | -0.40 | -0.60 | -50.00% |
| 2024-05-14 | -0.45 | -2.51 | -457.78% |
| 2024-03-28 | -0.34 | -0.15 | +55.76% |
| 2023-11-09 | -0.17 | -0.36 | -111.76% |
| 2023-08-09 | -0.16 | -0.46 | -187.50% |
| 2023-05-05 | 0.59 | -0.35 | -159.83% |
| 2023-03-16 | -0.67 | -0.64 | +5.19% |
| 2022-11-14 | -0.78 | -0.75 | +4.46% |
| 2022-08-05 | -0.93 | -0.74 | +20.43% |
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| IMNM | -3.96% | +1.35% | +1.63% | +149.20% |
| XLV | +2.97% | -4.64% | -3.44% | +12.69% |
| Alpha (stock − sector) | -6.93% | +5.98% | +5.07% | +136.51% |